This revised application aims to elucidate the role of casein kinase II in lymphomagenesis, particularly as mediated via cooperation with other oncogenes. This broadly expressed serine/threonine kinase has been found to be massively upregulated in reversible lymphoproliferative disease of cattle, and the slight overexpression of the CKIIa subunit in IgH transgenic mice leads to the slow acquisition of T cell lymphomas. Moreover, simultaneous overexpression of CKII and myc leads to the extremely rapid development of lymphomas. Based upon these data, the Applicant proposes three specific aims: 1)To measure the effects of overexpressed CKIIa' and CKIIb subunits, alone and in transgenic combination with CKIIa, on lymphomagenesis; 2)To test the hypothesis that CKII's effects are mediated by interaction with P53 by studies in CKII/P53+/- heterozygous KO mice; and 3)To study lymphomatous cell lines from CKII+ lymphomas to determine which of several lymphoid regulatory genes, including myc, myb, AP-1, p53, Rb, CREB, C/EBP, NFkB and NF-AT, might be activated by these cell lines. The Applicant believes that exploration of this system will provide insight into how post-translational modification of transcription factors by serine/threonine kinases can lead to their activation, and could contribute to the molecular pathogenesis of lymphomas and leukemias.

Agency
National Institute of Health (NIH)
Institute
National Cancer Institute (NCI)
Type
Research Project (R01)
Project #
1R01CA071796-01A1
Application #
2010176
Study Section
Hematology Subcommittee 2 (HEM)
Project Start
1997-05-01
Project End
2000-04-30
Budget Start
1997-05-01
Budget End
1998-04-30
Support Year
1
Fiscal Year
1997
Total Cost
Indirect Cost
Name
Boston Medical Center
Department
Type
DUNS #
005492160
City
Boston
State
MA
Country
United States
Zip Code
02118
Imbrie, Gregory A; Wu, Hao; Seldin, David C et al. (2012) Asymmetric Localization of CK2? During Xenopus Oogenesis. Hum Genet Embryol Suppl 4:11328
Landesman-Bollag, Esther; Belkina, Anna; Hovey, Beth et al. (2011) Developmental and growth defects in mice with combined deficiency of CK2 catalytic genes. Mol Cell Biochem 356:227-31
Dominguez, Isabel; Degano, Irene R; Chea, Kathleen et al. (2011) CK2? is essential for embryonic morphogenesis. Mol Cell Biochem 356:209-16
Currier, Nicolas; Chea, Kathleen; Hlavacova, Mirka et al. (2010) Dynamic expression of a LEF-EGFP Wnt reporter in mouse development and cancer. Genesis 48:183-94
Wu, Hao; Symes, Karen; Seldin, David C et al. (2009) Threonine 393 of beta-catenin regulates interaction with Axin. J Cell Biochem 108:52-63
Dominguez, I; Sonenshein, G E; Seldin, D C (2009) Protein kinase CK2 in health and disease: CK2 and its role in Wnt and NF-kappaB signaling: linking development and cancer. Cell Mol Life Sci 66:1850-7
Chitalia, Vipul C; Foy, Rebecca L; Bachschmid, Markus M et al. (2008) Jade-1 inhibits Wnt signalling by ubiquitylating beta-catenin and mediates Wnt pathway inhibition by pVHL. Nat Cell Biol 10:1208-16
Seldin, David C; Lou, David Y; Toselli, Paul et al. (2008) Gene targeting of CK2 catalytic subunits. Mol Cell Biochem 316:141-7
Lou, David Y; Dominguez, Isabel; Toselli, Paul et al. (2008) The alpha catalytic subunit of protein kinase CK2 is required for mouse embryonic development. Mol Cell Biol 28:131-9
Belguise, Karine; Guo, Shangqin; Yang, Shi et al. (2007) Green tea polyphenols reverse cooperation between c-Rel and CK2 that induces the aryl hydrocarbon receptor, slug, and an invasive phenotype. Cancer Res 67:11742-50

Showing the most recent 10 out of 22 publications